Enteric infections, diarrhea, and their impact on function and development.

Enteric infections, with or without overt diarrhea, have profound effects on intestinal absorption, nutrition, and childhood development as well as on global mortality. Oral rehydration therapy has reduced the number of deaths from dehydration caused by infection with an enteric pathogen, but it has not changed the morbidity caused by such infections. This Review focuses on the interactions between enteric pathogens and human genetic determinants that alter intestinal function and inflammation and profoundly impair human health and development. We also discuss specific implications for novel approaches to interventions that are now opened by our rapidly growing molecular understanding.

[1]  G. Young,et al.  A Randomized Controlled Trial of Glucose versus Amylase Resistant Starch Hypo-Osmolar Oral Rehydration Solution for Adult Acute Dehydrating Diarrhea , 2008, PloS one.

[2]  R. Haque,et al.  Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. , 2008, The Journal of infectious diseases.

[3]  J. O'Leary,et al.  Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. , 2007, Journal of virological methods.

[4]  M. Levine,et al.  Safety and Immunogenicity of CVD 1208S, a Live, Oral ΔguaBA Δsen Δset Shigella flexneri 2a Vaccine Grown on Animal-Free Media , 2007, Human vaccines.

[5]  L. Möller,et al.  Detection of diarrhoea-causing protozoa in general practice patients in The Netherlands by multiplex real-time PCR. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  M. Estes,et al.  An NSP4‐dependant mechanism by which rotavirus impairs lactase enzymatic activity in brush border of human enterocyte‐like Caco‐2 cells , 2007, Cellular microbiology.

[7]  J. Cisar,et al.  Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection. , 2007, Vaccine.

[8]  Mark A. Miller,et al.  Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005 , 2007, Epidemiology and Infection.

[9]  J. Crump,et al.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984–2005 , 2007, Epidemiology and Infection.

[10]  J. Crump,et al.  Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984–2005 , 2007, Epidemiology and Infection.

[11]  M. Sztein Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Levine,et al.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road , 2007, Nature Reviews Microbiology.

[13]  R. Guerrant,et al.  Enteroaggregative Escherichia coli in Venda, South Africa: distribution of virulence-related genes by multiplex polymerase chain reaction in stool samples of human immunodeficiency virus (HIV)-positive and HIV-negative individuals and primary school children. , 2007, The American journal of tropical medicine and hygiene.

[14]  N. Thomas,et al.  Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation , 2007, Gut.

[15]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[16]  S. Powell,et al.  Prevalence of Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods. , 2007, The Journal of infection.

[17]  S. Tzipori,et al.  Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  G. Glenn,et al.  Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. , 2007, Vaccine.

[19]  M. Plebani,et al.  Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn’s Disease , 2007, Diseases of the colon and rectum.

[20]  G. Perez-Perez,et al.  Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer , 2007, BMC Cancer.

[21]  Rashidul Haque,et al.  Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. , 2007, The American journal of tropical medicine and hygiene.

[22]  H. Dupont,et al.  A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Martines,et al.  Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease , 2007, International Journal of Colorectal Disease.

[24]  R. Guerrant,et al.  Wasting and Intestinal Barrier Function in Children Taking Alanyl-Glutamine–Supplemented Enteral Formula , 2007, Journal of pediatric gastroenterology and nutrition.

[25]  P. Sansonetti,et al.  Debugging how bacteria manipulate the immune response. , 2007, Immunity.

[26]  J. Turner,et al.  Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. , 2007, The Journal of clinical investigation.

[27]  D. Sack,et al.  Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. , 2007, Vaccine.

[28]  B. Corthésy Roundtrip Ticket for Secretory IgA: Role in Mucosal Homeostasis?1 , 2007, The Journal of Immunology.

[29]  A. Hill Aspects of genetic susceptibility to human infectious diseases. , 2006, Annual review of genetics.

[30]  R. Haque,et al.  Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  Mark A. Miller,et al.  Review of reported cholera outbreaks worldwide, 1995-2005. , 2006, The American journal of tropical medicine and hygiene.

[32]  Jenefer M Blackwell,et al.  Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? , 2006, The Lancet Infectious Diseases.

[33]  R. Guerrant,et al.  Infectious diarrhea: new pathogens and new challenges in developed and developing areas. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Edberg,et al.  Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Wells,et al.  Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  T. Ochoa,et al.  Effect of lactoferrin on enteroaggregative E. coli (EAEC). , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[37]  H. Binder,et al.  Zinc in the treatment of acute diarrhea: current status and assessment. , 2006, Gastroenterology.

[38]  S. Moore,et al.  Early Childhood Diarrhea Predicts Impaired School Performance , 2006, The Pediatric infectious disease journal.

[39]  M. Levine,et al.  Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model. , 2006, Vaccine.

[40]  A. L. Bourgeois,et al.  Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. , 2006, Vaccine.

[41]  M. Larocco,et al.  A Common Polymorphism in the Interleukin 8 Gene Promoter Is Associated with Clostridium difficile Diarrhea , 2006, The American Journal of Gastroenterology.

[42]  J. Dziura,et al.  Amylase-Resistant Starch as Adjunct to Oral Rehydration Therapy in Children with Diarrhea , 2006, Journal of pediatric gastroenterology and nutrition.

[43]  E. Oaks,et al.  Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. , 2006, Vaccine.

[44]  R. Haque,et al.  Cognitive effects of diarrhea, malnutrition, and Entamoeba histolytica infection on school age children in Dhaka, Bangladesh. , 2006, The American journal of tropical medicine and hygiene.

[45]  R. Haque,et al.  Entamoeba histolytica Infection in Children and Protection from Subsequent Amebiasis , 2006, Infection and Immunity.

[46]  R. R. Henry,et al.  Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin‐1 and ‐10 genes , 2006, International journal of cancer.

[47]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[48]  J. O’Neill,et al.  Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. , 2006, Vaccine.

[49]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[50]  J. Heyse,et al.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.

[51]  E. Jirillo,et al.  New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease , 2006, Immunopharmacology and immunotoxicology.

[52]  M. Wolf,et al.  Community-Based Safety, Immunogenicity, and Transmissibility Study of the Shigella sonnei WRSS1 Vaccine in Israeli Volunteers , 2005, Infection and Immunity.

[53]  A. Cheng,et al.  Infectious diarrhea in developed and developing countries. , 2005, Journal of clinical gastroenterology.

[54]  P. Brandtzaeg,et al.  Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties , 2005, Immunological reviews.

[55]  H. Rautelin,et al.  Genetic and Environmental Factors in the Immunopathogenesis of Atopy: Interaction of Helicobacter pylori Infection and IL4 Genetics , 2005, International Archives of Allergy and Immunology.

[56]  M. Sztein,et al.  Immunization of Volunteers with Salmonella enterica Serovar Typhi Strain Ty21a Elicits the Oligoclonal Expansion of CD8+ T Cells with Predominant Vβ Repertoires , 2005, Infection and Immunity.

[57]  A. Talavera,et al.  The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers , 2005, Infection and Immunity.

[58]  H. Binder,et al.  Zinc inhibits cAMP-stimulated Cl secretion via basolateral K-channel blockade in rat ileum. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[59]  Jan Holmgren,et al.  Mucosal immunity and vaccines , 2005, Nature Medicine.

[60]  J. Ball,et al.  Rotavirus NSP4: a multifunctional viral enterotoxin. , 2005, Viral immunology.

[61]  Robert E Black,et al.  WHO estimates of the causes of death in children , 2005, The Lancet.

[62]  T. Monath,et al.  Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. , 2005, Gastroenterology.

[63]  J. Clemens,et al.  Effectiveness of mass oral cholera vaccination in Beira, Mozambique. , 2005, The New England journal of medicine.

[64]  M. Rugge,et al.  Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. , 2005, Cytokine.

[65]  R. Guerrant,et al.  APOE4 Protects the Cognitive Development in Children with Heavy Diarrhea Burdens in Northeast Brazil , 2005, Pediatric Research.

[66]  A. Kantele,et al.  Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter. , 2005, The Journal of infectious diseases.

[67]  M. Jenkins Present and future control of cryptosporidiosis in humans and animals , 2004, Expert review of vaccines.

[68]  M. Mckendrick,et al.  A review of viral gastroenteritis , 2004, Current opinion in infectious diseases.

[69]  H. García-Lozano,et al.  Diarrhea Morbidity and Mortality in Mexican Children: Impact of Rotavirus Disease , 2004, The Pediatric infectious disease journal.

[70]  M. Levine,et al.  Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. , 2004, The Journal of infectious diseases.

[71]  Baohua Zhao,et al.  The humoral and cellular immune responses in mice induced by DNA vaccine expressing the sporozoite surface protein of Cryptosporidium parvum. , 2004, DNA and cell biology.

[72]  H. Oshitani,et al.  Can oral cholera vaccination play a role in controlling a cholera outbreak? , 2004, Vaccine.

[73]  S. Piscitelli,et al.  Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  M. Rao Oral rehydration therapy: new explanations for an old remedy. , 2004, Annual review of physiology.

[75]  M. Wolf,et al.  Two Studies Evaluating the Safety and Immunogenicity of a Live, Attenuated Shigella flexneri 2a Vaccine (SC602) and Excretion of Vaccine Organisms in North American Volunteers , 2004, Infection and Immunity.

[76]  T. Beaty,et al.  Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. , 2004, The Journal of infectious diseases.

[77]  Robert E Black,et al.  Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community , 2004, The Lancet.

[78]  S. Saxena,et al.  Zinc With Oral Rehydration Therapy Reduces Stool Output and Duration of Diarrhea in Hospitalized Children: A Randomized Controlled Trial , 2004, Journal of pediatric gastroenterology and nutrition.

[79]  J. Vanderhoof,et al.  Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. , 2003, Best practice & research. Clinical gastroenterology.

[80]  D. Mara,et al.  Water, sanitation and hygiene for the health of developing nations. , 2003, Public health.

[81]  S. Szu,et al.  Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. , 2003, The New England journal of medicine.

[82]  R. Haque,et al.  Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. , 2003, The American journal of tropical medicine and hygiene.

[83]  E. Kunkel,et al.  Plasma-cell homing , 2003, Nature Reviews Immunology.

[84]  C. Tacket,et al.  Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. , 2003, Clinical immunology.

[85]  D. Milewicz,et al.  Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. , 2003, The Journal of infectious diseases.

[86]  J. Nougayrède,et al.  Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. , 2003, Microbes and infection.

[87]  Robert E Black,et al.  Where and why are 10 million children dying every year? , 2003, The Lancet.

[88]  M. Camilleri,et al.  Fecal Lactoferrin Is a Sensitive and Specific Marker in Identifying Intestinal Inflammation , 2003, American Journal of Gastroenterology.

[89]  Xi Jiang,et al.  Human susceptibility and resistance to Norwalk virus infection , 2003, Nature Medicine.

[90]  R. Guerrant,et al.  Glutamine analogues as adjunctive therapy for infectious diarrhea , 2003, Current infectious disease reports.

[91]  Caryn Bern,et al.  The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. , 2003, Bulletin of the World Health Organization.

[92]  G. Kang,et al.  Faecal lactoferrin as a predictor of positive faecal culture in south Indian children with acute diarrhoea , 2003, Annals of tropical paediatrics.

[93]  B. Müller-Myhsok,et al.  Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. , 2003, American journal of human genetics.

[94]  G. Losonsky,et al.  B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals. , 2003, Vaccine.

[95]  T. Ottenhoff,et al.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae , 2002, Nature Genetics.

[96]  R. Guerrant,et al.  Updating the DALYs for diarrhoeal disease. , 2002, Trends in parasitology.

[97]  S. Moore,et al.  Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. , 2002, The American journal of tropical medicine and hygiene.

[98]  G. Fick,et al.  Arginine supplementation prevents necrotizing enterocolitis in the premature infant. , 2002, The Journal of pediatrics.

[99]  H. Dupont,et al.  Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. , 2002, The Journal of infectious diseases.

[100]  D. S. Berkman,et al.  Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study , 2002, The Lancet.

[101]  M. Conaway,et al.  Early childhood diarrhoea and helminthiases associate with long-term linear growth faltering. , 2001, International journal of epidemiology.

[102]  R. Guerrant,et al.  Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[103]  G. Hecht Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[104]  David N. Taylor,et al.  Safety and Immunogenicity of a Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults , 2001, Infection and Immunity.

[105]  J. Shiloach,et al.  The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. , 2001, The New England journal of medicine.

[106]  J. DeSesso,et al.  Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[107]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[108]  C. Colton,et al.  Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. , 2001, Biochimica et biophysica acta.

[109]  J. Wain,et al.  Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. , 2001, The Journal of infectious diseases.

[110]  G. Dougan,et al.  Phase 2 Clinical Trial of AttenuatedSalmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers , 2000, Infection and Immunity.

[111]  D. D. Trach,et al.  Phase 1 and Phase 2 Studies of Salmonella enterica Serovar Paratyphi A O-Specific Polysaccharide-Tetanus Toxoid Conjugates in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam , 2000, Infection and Immunity.

[112]  G. Young,et al.  Amylase-resistant starch plus oral rehydration solution for cholera. , 2000, The New England journal of medicine.

[113]  P. Lunn,et al.  The impact of infection and nutrition on gut function and growth in childhood , 2000, Proceedings of the Nutrition Society.

[114]  S. Moore,et al.  Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. , 1999, The American journal of tropical medicine and hygiene.

[115]  C. Hayden,et al.  Polymorphisms in the β2‐adrenoreceptor gene are associated with decreased airway responsiveness , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[116]  R H Gilman,et al.  Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. , 1998, American journal of epidemiology.

[117]  D. Scott,et al.  Vaccines against Campylobacter jejuni. , 1997, The Journal of infectious diseases.

[118]  Manfred S. Green,et al.  Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults , 1997, The Lancet.

[119]  L. Epstein,et al.  Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. , 1997, American journal of epidemiology.

[120]  S. Miller,et al.  phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. , 1996, The Journal of infectious diseases.

[121]  D. Mahalanabis,et al.  The effect of L-glutamine on salt and water absorption: a jejunal perfusion study in cholera in humans. , 1996, European journal of gastroenterology & hepatology.

[122]  S. E. Brodie New York, New York, USA , 1996 .

[123]  M. Levine,et al.  Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. , 1995, Journal of immunology.

[124]  R. Black,et al.  Zinc supplementation in young children with acute diarrhea in India. , 1995, The New England journal of medicine.

[125]  P. Sansonetti,et al.  Role of interleukin-1 in the pathogenesis of experimental shigellosis. , 1995, The Journal of clinical investigation.

[126]  C. Pothoulakis,et al.  Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. , 1994, Gastroenterology.

[127]  O. Fontaine,et al.  Treatment of acute diarrhea with oral rehydration solutions containing glutamine. , 1994, Journal of the American College of Nutrition.

[128]  L. Johnson,et al.  Physiology of the gastrointestinal tract , 2012 .

[129]  U. Wingren,et al.  Nerve involvement in fluid transport in the inflamed rat jejunum. , 1993, Gut.

[130]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[131]  M. Levine,et al.  Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection , 1993, Infection and immunity.

[132]  D. Crompton,et al.  Ascariasis and childhood malnutrition. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[133]  R. Schneerson,et al.  Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[134]  G. Barnes,et al.  Role of coproantibody in clinical protection of children during reinfection with rotavirus , 1992, Journal of clinical microbiology.

[135]  L. Mata Diarrheal disease as a cause of malnutrition. , 1992, The American journal of tropical medicine and hygiene.

[136]  R. Guerrant,et al.  Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. , 1992, The American journal of tropical medicine and hygiene.

[137]  R. Guerrant,et al.  Measurement of fecal lactoferrin as a marker of fecal leukocytes , 1992, Journal of clinical microbiology.

[138]  R. Giannella,et al.  Escherichia coli enterotoxin (STa) binds to receptors, stimulates guanyl cyclase, and impairs absorption in rat colon. , 1992, Gastroenterology.

[139]  P. Lunn,et al.  Intestinal permeability, mucosal injury, and growth faltering in Gambian infants , 1991, The Lancet.

[140]  A. Kantele,et al.  Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. , 1991, Vaccine.

[141]  R. Jonsson,et al.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans , 1991, Infection and immunity.

[142]  H. Binder,et al.  Characterization of butyrate-dependent electroneutral Na-Cl absorption in the rat distal colon , 1990, Pflügers Archiv.

[143]  A. Kantele Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. , 1990, Vaccine.

[144]  R. Guerrant,et al.  Diarrhoea and catch-up growth , 1990, The Lancet.

[145]  M. Rennels,et al.  Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. , 1988, The Pediatric infectious disease journal.

[146]  P. Andersen,et al.  Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.

[147]  B. Stoll,et al.  Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. , 1985, American journal of epidemiology.

[148]  J. Moss,et al.  Mechanism of action of choleragen andE. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation , 1981, Molecular and Cellular Biochemistry.

[149]  J. Cassuto,et al.  On the role of intramural nerves in the pathogenesis of cholera toxin-induced intestinal secretion. , 1981, Scandinavian journal of gastroenterology.

[150]  R. D. Montgomery,et al.  Evaluation of xylose absorption as measured in blood and urine: A one-hour blood xylose screening test in malabsorption , 1978 .

[151]  J. Hughes,et al.  Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli , 1978, Nature.

[152]  Q. Al-Awqati,et al.  Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. , 1972, The Journal of clinical investigation.

[153]  R. Guerrant,et al.  Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation. , 1972, The Journal of infectious diseases.

[154]  D. Dale,et al.  Studies of diarrheal disease in Central America. XI. Intestinal bacterial flora in malnourished children with shigellosis. , 1968, The American journal of tropical medicine and hygiene.

[155]  Fordtran Js Speculations on the pathogenesis of diarrhea. , 1967 .

[156]  N. Scrimshaw,et al.  Studies of diarrheal disease in Central America. 8. Measles, diarrhea, and nutritional deficiency in rural Guatemala. , 1966, The American journal of tropical medicine and hygiene.

[157]  J. Blangero,et al.  Localization of multiple quantitative trait loci influencing susceptibility to infection with Ascaris lumbricoides. , 2008, The Journal of infectious diseases.

[158]  R. Guerrant,et al.  Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development. , 2007, Medical hypotheses.

[159]  D. Jamison,et al.  Diarrheal Diseases -- Disease Control Priorities in Developing Countries , 2006 .

[160]  T. Shirakawa,et al.  An asthma-associated genetic variant of STAT6 predicts low burden of ascaris worm infestation , 2004, Genes and Immunity.

[161]  W. Petri,et al.  Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. , 2004, Vaccine.

[162]  W. Mendoza,et al.  Improving diarrhoea estimates. , 2002 .

[163]  J. Galán,et al.  Salmonella interactions with host cells: type III secretion at work. , 2001, Annual review of cell and developmental biology.

[164]  D. Swerdlow,et al.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. , 1999, Bulletin of the World Health Organization.

[165]  R. Guerrant,et al.  Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. , 1998, The Journal of infectious diseases.

[166]  M. Farthing,et al.  Enhancing clinical efficacy of oral rehydration therapy: is low osmolality the key? , 1998, Gastroenterology.

[167]  R. Guerrant,et al.  Cotransport of sodium with glutamine, alanine and glucose in the isolated rabbit ileal mucosa. , 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[168]  L. Mata The children of Santa María Cauqué: a prospective field study of health and growth. , 1978 .